Answers are grounded in this paper and cite their sources.
Retrospective cohort study analyzes clinical and imaging outcomes in patients with vertebral artery stenosis, highlighting safety and efficacy.
BACKGROUND: Dedicated sirolimus-eluting stents designed for vertebral artery origin anatomy have recently been introduced for the treatment of symptomatic vertebral artery origin stenosis (VAOS). However, real-world data on predefined 1-year imaging outcomes and device-related complications remain limited. METHODS: This single-center retrospective cohort study included consecutive patients with symptomatic VAOS treated with dedicated sirolimus-eluting vertebral artery stents between January 2021 and November 2024. Periprocedural complications, 1-year clinical outcomes, modified Rankin Scale (mRS) scores, and imaging findings were analyzed. Logistic regression was used to identify predictors of in-stent restenosis (ISR). Exploratory analyses compared outcomes between different stent platforms. RESULTS: A total of 168 patients were included, and technical success was achieved in all procedures. Periprocedural complications occurred in 5.5%, including major events in 1.2%. At 1 year, ISR occurred in 13% and was predominantly asymptomatic, while stent fracture was observed in 12%. During follow-up, transient ischemic attack occurred in 1.8%, target-vessel-related ischemic stroke in 1.2%, and non-target-vessel ischemic stroke in 2.4%. Major bleeding occurred in 0.6%, and all-cause mortality was 1.2%. Functional status improved significantly and remained improved at 1 year (P < 0.001). Severe stenosis or occlusion of the contralateral vertebral artery independently predicted ISR (adjusted OR 4.50; 95% CI 1.81-11.19; P = 0.001). Clinical and imaging outcomes were comparable between stent platforms. CONCLUSIONS: Dedicated sirolimus-eluting vertebral artery stenting appears safe and effective in real-world practice, with acceptable 1-year patency and sustained functional improvement. Contralateral vertebral artery disease independently predicts ISR, highlighting the role of posterior circulation hemodynamics.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: